Sandra Horning
Director/Board Member at GILEAD SCIENCES, INC.
Net worth: 4 M $ as of 2024-04-29
Profile
Dr. Sandra J.
Horning, MD, is an Independent Director at Revolution Medicines, Inc., an Independent Director at Olema Pharmaceuticals, Inc., an Independent Director at Moderna, Inc., an Independent Director at Gilead Sciences, Inc. and a Professor-Emeritus at Stanford University School of Medicine.
She is on the Board of Directors at Revolution Medicines, Inc., Cellarity Inc., Olema Pharmaceuticals, Inc., Moderna, Inc. and Gilead Sciences, Inc. Dr. Horning was previously employed as a Co-Founder by EQRx International, Inc., an Independent Director by EQRx, Inc., a Chief Medical Officer & Head-Product Development by Roche, Inc., an EVP-Global Development by Genentech, Inc., a Chief Medical Officer by Roche Holdings, Inc., and a President by American Society of Clinical Oncology, Inc. She also served on the board at Foundation Medicine, Inc. She received her undergraduate degree from the University of Iowa and a doctorate degree from the University of Iowa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 90,638 ( 0.06% ) | 3 M $ | 2024-04-29 | |
GILEAD SCIENCES, INC.
0.00% | 2024-05-07 | 3,631 ( 0.00% ) | 236 995 $ | 2024-04-29 |
MODERNA, INC.
0.00% | 2024-05-05 | 1,373 ( 0.00% ) | 145 785 $ | 2024-04-29 |
| 2024-04-22 | 0 ( -.--% ) | - $ | 2024-04-29 |
Sandra Horning active positions
| Companies | Position | Start |
|---|---|---|
| GILEAD SCIENCES, INC. | Director/Board Member | 2020-01-27 |
| MODERNA, INC. | Director/Board Member | 2020-02-29 |
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 2020-11-12 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 2023-11-08 |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 2022-05-08 |
Former positions of Sandra Horning
| Companies | Position | End |
|---|---|---|
| EQRX, INC. | Founder | 2023-11-08 |
| Roche, Inc. | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Sandra Horning
| University of Iowa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| EQRX, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Roche Holdings, Inc.
Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Finance |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
| Roche, Inc. | |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Sandra Horning
